Horizon Pharma plc is a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. We market 11 medicines through our rare disease, rheumatology and primary care business units.

Our goal is to build a new kind of biopharmaceutical company; one that challenges industry norms and believes that when patients benefit, everyone benefits.